SCHEMBL6847771

SCHEMBL6847771

COC(=O)C1=C(OC)N=C(OC)N(C(=O)Oc2ccc([N+](=O)[O-])cc2)C1c1ccc2nonc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
CACNA1F O60840 2/20 0.37
CACNA1D Q01668 2/20 0.37
CACNA1S Q13698 2/20 0.37
CACNA1C Q13936 2/20 0.37
MAPT P10636 3/20 0.35
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
GAA P10253 2/20 0.34
NPC1 O15118 1/20 0.34
POLB P06746 1/20 0.34
RAB9A P51151 1/20 0.34
ADRA1D P25100 1/20 0.34
ADRA1A P35348 1/20 0.34
ADRA1B P35368 1/20 0.34
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6641617 0.92 CACNA1F (0.41) MEN1KMT2ACACNA1FCACNA1DCACNA1S
SCHEMBL6669528 0.80 CACNA1F (0.41) MEN1KMT2ACACNA1FCACNA1DCACNA1S
SCHEMBL6199441 0.79 MEN1 (0.44) MEN1KMT2ACACNA1FCACNA1DCACNA1S
SCHEMBL6194063 0.77 CACNA1F (0.41) MEN1KMT2ACACNA1FCACNA1DCACNA1S
SCHEMBL3988068 0.76 MGLL (0.41) MEN1KMT2ACACNA1FCACNA1DCACNA1S
SCHEMBL6646229 0.75 ADRA1D (0.39) MEN1KMT2ACACNA1FCACNA1DCACNA1S
SCHEMBL6784838 0.74 ADRA1A (0.39) MEN1KMT2ACACNA1FCACNA1DCACNA1S
SCHEMBL6195392 0.74 CACNA1F (0.40) MEN1KMT2ACACNA1FCACNA1DCACNA1S
SCHEMBL14760554 0.73 ALDH1A1 (0.43) MEN1KMT2ACACNA1FCACNA1DCACNA1S
SCHEMBL7529769 0.72 MGLL (0.36) MEN1KMT2ACACNA1FCACNA1DCACNA1S

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040242609-A1 Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof SYNAPTIC PHARMACEUTICAL CORPORATION 2004-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040242609-A1 Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof MCHR1, MCHR2, MC4R MEN1 358/4885KMT2A 1155/4885CACNA1F 4253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.